CVE-2025-1390

pam_cap: Fix potential configuration parsing error

Description

The PAM module pam_cap.so of libcap configuration supports group names starting with “@”, during actual parsing, configurations not starting with “@” are incorrectly recognized as group names. This may result in nonintended users being granted an inherited capability set, potentially leading to security risks. Attackers can exploit this vulnerability to achieve local privilege escalation on systems where /etc/security/capability.conf is used to configure user inherited privileges by constructing specific usernames.

Remediation

Solution:

  • https://git.kernel.org/pub/scm/libs/libcap/libcap.git/commit/?id=1ad42b66c3567481cc5fa22fc1ba1556a31... https://git.kernel.org/pub/scm/libs/libcap/libcap.git/commit/

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.02%
Affected: OpenAnolis Anolis OS
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-1390?
CVE-2025-1390 has been scored as a medium severity vulnerability.
How to fix CVE-2025-1390?
To fix CVE-2025-1390: https://git.kernel.org/pub/scm/libs/libcap/libcap.git/commit/?id=1ad42b66c3567481cc5fa22fc1ba1556a31... https://git.kernel.org/pub/scm/libs/libcap/libcap.git/commit/
Is CVE-2025-1390 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-1390 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-1390?
CVE-2025-1390 affects OpenAnolis Anolis OS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.